EUROPEAN OPHTHALMIC REVIEW – VOLUME 11 – ISSUE 2 – WINTER 2017
We are delighted to introduce the winter edition of European Ophthalmic Review.
This issue begins with a selection of expert interviews covering topics presented at key meetings from the year. Our Editor-in-Chief Maurizio Battaglia Parodi tells us about his highlights from EURETINA including the latest research into diabetic macular edema treatments and imaging modalitites, and Andrzej Grzybowski discusses the current status and recent advances in the treatment of mypoia.
We also have a selection of review articles for you to enjoy. Ina Conrad-Hengerer and colleagues explore new steps and algorithms for precise measuring and intraocular lens calculations and Burak Turgut provides an update on presbyopia-correcting drops.
We hope you find this content useful and relevant to your day-to-day clinical practice. We are currently preparing our 2018 editions and would be delighted to work with you. Please see our Call for Submissions for further information. Submissions can be made here.
Call for Submissions
Call for Submissions 2018 – European Ophthalmic Review, 2017;11(2):81
Welcome to the Winter edition of European Ophthalmic Review. I am pleased to announce that we are now accepting submissions to the Summer and Winter 2018 editions. Authors are invited to submit original research, review articles, case reports and editorials across topical areas within their specialty. Articles of particular interest include real-world studies and review […]
The Importance of Diagnosing Ectatic Corneal Disease
Ectatic corneal disease (ECD) or corneal ectasia is a group of progressive eye disorders characterised by thinning and bulging of the cornea, and can result in moderate to severe impairment of vision. Recent advances in corneal imaging systems allow for the detection of mild or subclinical stages of the disease, which is fundamental in the […]
Treatment of Myopia – Current Status and Recent Advances
The incidence of myopia is increasing and represents a major global economic and social burden.1 In addition to its disadvantages in terms of vision, myopia increases the risk of myopic macular degeneration, retinal detachment, glaucoma and cataract and is a leading cause of visual impairment and blindness worldwide.2 Pharmacological, environmental and optical interventions have been […]
Recent Developments in Glaucoma
Glaucoma continues to exert a heavy disability and economic burden and is the most frequent cause of irreversible blindness worldwide.1 In 2015, 57.5 million people globally were affected by open-angle glaucoma and this is predicted to increase to 65.5 million by 2020.2 The prevalence of glaucoma increases with age in all populations and generally more […]
Advances in Retinal Disease Treatment and Diagnosis 2017
Retinal disease is a major cause of poor vision especially in the ageing population, and age related macular degeneration is the main cause of vision loss in the developed world.1,2 Early recognition of the signs and symptoms of retinal disease can help prevent ophthalmologic complications and vision loss. It is unsurprising, therefore that retinal imaging […]
Progress in Modern Cataract Surgery – New Steps and Algorithms for Precise Measuring and Intraocular-lens Calculations
Cataract surgery had undergone major improvements in different areas over the last 10 years. New intraocular lens (IOL) designs and fourth generation IOL formulae are available, allowing spectacle independence for many patients. Femtosecond laser-assisted cataract surgery (FLACS) has been introduced, and the options seen on television and web-based sources have increased patients’ understanding and raised […]
Update on Presbyopia-correcting Drops
Presbyopia is progressive age-related reduction in accommodation amplitude and the loss of ability of the eye to focus on near objects. It occurs in almost everyone at around 40 years of age.1–5 Presbyopia affects visual tasks at near distance such as book reading, handcrafts, stitching, cooking and surgical operation. Thus, it causes the diminishing of […]
Early Clinical Experiences with Brinzolamide/Brimonidine Fixed Combination in Open-angle Glaucoma and Ocular Hypertension
Glaucoma is the second most common cause of blindness overall, and the leading cause of irreversible blindness, and constitutes a serious worldwide disability burden.1 In 2015, 57.5 million people globally were affected by open-angle glaucoma (OAG) and this is predicted to increase to 65.5 million by 2020. Prevalence increases sharply with increasing age in all […]
Review of Diabetic Macular Oedema Therapy
As our life expectancy, along with our sedentary lifestyles increase, the prevalence of diabetes mellitus increases as well. With increasing prevalence and duration of diabetes, the incidence and prevalence of diabetic retinopathy grows as well. Diabetic macular oedema (DMO) is a frequent cause of vision loss in people with diabetes and is one of the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!